Cargando…
OA21 Ankylosing Spondylitis management with Secukinumab but related Inflammatory bowel disease phenomenon
INTRODUCTION/BACKGROUND: Ankylosing spondylitis is a HLA B27 associated inflammatory spondyloarthropathy. It can be a debilitating disease affecting mobility and quality of life, therefore, effective symptom and disease control is crucial and consists of pharmacological, including biologics, and non...
Autores principales: | Iqbal, Sultan, Basit, Abdul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515824/ http://dx.doi.org/10.1093/rap/rkac066.021 |
Ejemplares similares
-
OA01.04. Management of ankylosing spondylitis through ayurvedic medicine along with agnikarma- A case study
por: Tamrakar, Anupam, et al.
Publicado: (2012) -
Secukinumab for ankylosing spondylitis and psoriatic arthritis
por: Lubrano, Ennio, et al.
Publicado: (2016) -
Secukinumab: A Review in Ankylosing Spondylitis
por: Blair, Hannah A.
Publicado: (2019) -
Correction to: Secukinumab: A Review in Ankylosing Spondylitis
por: Blair, Hannah A.
Publicado: (2019) -
Role of secukinumab in ankylosing spondylitis with tubercular uveitis
por: Mahendradas, Padmamalini, et al.
Publicado: (2020)